Bryan D. Smith
Bryan D. Smith publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Ubiquitin and proteasome pathways, Cancer, Hypoxia, and Metabolism and Gastrointestinal Tumor Research and Treatment.
- World rank
- #358,531 of 7,710,434 ranked researchers
- Rank in United States
- #128,318 of 1,627,098
- Works
- 150
- Citations
- 2.4k
- Citations per work
- 16.2
What does Bryan D. Smith research?
Bryan D. Smith's work is mostly in Biochemistry, Genetics and Molecular Biology (34%), Medicine (23%), Chemistry (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5738.3%
- Life Sciences5134.3%
- Health Sciences3523.3%
- Medicine3523.3%
- Physical Sciences64.1%
- Chemistry64.1%
- 1Molecular Biology28% of their works
- 2Oncology10% of their works
- 3Pulmonary and Respiratory Medicine8% of their works
- 4Cancer Research6% of their works
- 5Hematology5% of their works
- 6Organic Chemistry4% of their works
Research topics
Which keywords describe Bryan D. Smith's research?
The keywords of their largest research topics: Cancer Therapy, Prognostic Factors, Proteasome, Ubiquitin, HIF-1, Imatinib Mesylate, Sunitinib and Warburg Effect.
- Tumor Targeting
- Protein Kinases
- endothelial progenitor cells
- Soft Tissue Sarcoma
- Imatinib
- Warburg Effect
- Imatinib Mesylate
- Ubiquitin
- Prognostic Factors
- Cancer Therapy
- Proteasome
- HIF-1
- Sunitinib
- BCR-ABL
- Osteosarcoma
- VEGF
- Bacterial Therapy
- Ras Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Cancer Therapy172 topics
- Prognostic Factors172 topics
- Proteasome101 topic
- Ubiquitin101 topic
- HIF-191 topic
- Imatinib Mesylate91 topic
- Sunitinib91 topic
- Warburg Effect91 topic
- BCR-ABL81 topic
- Imatinib81 topic
- Osteosarcoma81 topic
- Soft Tissue Sarcoma81 topic
- VEGF81 topic
- endothelial progenitor cells81 topic
- Bacterial Therapy71 topic
- Protein Kinases71 topic
- Ras Signaling71 topic
- Tumor Targeting71 topic
Where does Bryan D. Smith work?
Bryan D. Smith's main affiliation in the publication record is Deciphera Pharmaceuticals (United States), United States.
How many publications and citations does Bryan D. Smith have?
OpenAlex counts 150 works and 2,434 citations for Bryan D. Smith, an h-index of 23, ranking #358,531 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bryan D. Smith. Posts are plain text and can be reported.